Impact of a Structured Therapeutic Education Session on the Practice of Adapted Physical Activity in Chronic Inflammatory Bowel Diseases

Condition(s) studied

Investigational drug(s) / intervention(s)

Inflammatory Bowek Disk Questionnaires: Patients will be asked to complete the questionnaires regarding bowel inflammation at enrollment, 6 months later, and 12 months later.

Short-International Physical Activity Questionnaries: Patients will be asked to complete the physical activity questionnaire 6 months later and 12 months later.

Study summary

Chronic inflammatory bowel diseases (IBD; including Crohn's disease and ulcerative colitis) significantly impact patients' quality of life. Among non-pharmacological therapies, adapted physical activity (APA) has demonstrated its beneficial impact, particularly on fatigue, anxiety, digestive symptoms, and the overall quality of life of patients with IBD.

The real-world implementation of APA remains insufficient, primarily due to limited patient adherence to this prescription.

Patient therapeutic education (PTE) represents a potentially powerful lever for promoting engagement in APA by addressing barriers related to a lack of awareness (fear of symptom worsening) and lack of motivation. No dedicated study has specifically evaluated the effect of targeted PTE sessions on adherence to physical activity in IBD.

The objective of the present feasibility study will be to determine whether a single therapeutic education session focused on the digestive and systemic benefits of APA has an impact on the rate of physical activity practice in the medium term among patients with IBD in clinical remission for at least 3 months.

Eligibility

Primary outcome measure(s)

• Effectiveness of therapeutic education intervention on physical activity practice — 12 months after the inclusion
  Measure the amount of metabolic equivalent or MET/Week (Metabolic Equivalent Task) at 12 months, based on the short-IPAQ questionnaire assessing physical activities reported by the patient over the last 7 days.

Trial sites (1)

More University Hospital, Toulouse trials in France